|Bid||0.0000 x 1000|
|Ask||0.0000 x 900|
|Day's Range||1.4932 - 1.6900|
|52 Week Range||1.1600 - 9.4900|
|Beta (5Y Monthly)||1.35|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jul 25, 2022 - Jul 29, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||4.08|
Subscribe to Yahoo Finance Plus to view Fair Value for MEDS
TAMPA, FL / ACCESSWIRE / May 19, 2022/ TRxADE HEALTH, INC. (NASDAQ:MEDS) an integrated drug procurement, delivery, and healthcare platform, today announced that Bonum Health, a Digital Healthcare business subsidiary, has launched Tele-Veterinary services for pets.
TRxADE (MEDS) delivered earnings and revenue surprises of -33.33% and 37.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Continues Nationwide Expansion of Breakthrough Digital Healthcare Services IT PlatformTAMPA, FL / ACCESSWIRE / May 9, 2022 / TRxADE HEALTH, INC. (NASDAQ:MEDS)("TRxADE" or the "Company"), a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.